Frazier Healthcare Partners (Growth Buyout)
Seattle's healthcare heavyweight. The Growth Buyout arm targets provider services and pharma services companies with $5M to $50M of EBITDA, backed by a $2.3B fund and an executive network cultivated over three decades.
| Headquarters | Seattle, Washington |
|---|---|
| Fund size / AUM | Growth Buyout Fund XI $2.3B (2024); AUM >$6.2B |
| Check size / target EBITDA | Target EBITDA $5M-$50M |
| Target company size | $15M-$40M EBITDA |
| Sector focus | Healthcare provider services, pharma services (Growth Buyout arm; life-sciences VC arm excluded) |
| Strategy | Buyout |
| Website | frazierhealthcare.com |
Compiled from Frazier Healthcare Partners (Growth Buyout)'s website and public announcements. Numbers change as new funds close; treat this as a starting point, not a term sheet. Report a correction.
Selling to a firm like this?
Buyers like Frazier Healthcare Partners (Growth Buyout) will test your numbers before they trust them.
Crawford McMillan gets mid-market companies diligence-ready: revenue you can trace, metrics you can defend, reporting that holds up in a data room. Free weekly brief on what buyers actually look for.
Get Inside the Data Room